Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling

Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling

Multiple sclerosis (MS) is known as an autoimmune disease in the central nervous system (CNS) characterized by motor deficits, pain, fatigue, cognitive impairment, and sensory and visual dysfunction. MS is considered to be resulted from significant inflammatory response. Paricalcitol (Pari) is a vit...

Full description

Bibliographic Details
Main Authors: Dangfeng Zhang, Lin Qiao, Ting Fu
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Multiple sclerosis (MS)
Paricalcitol (Pari)
EAE
Inflammation
NF-κB
Online Access:http://www.sciencedirect.com/science/article/pii/S075333221933505X

Internet

http://www.sciencedirect.com/science/article/pii/S075333221933505X

Similar Items